NEW YORK and LAVAL, Quebec, Feb. 08, 2016 (GLOBE NEWSWIRE) — Colgate-Palmolive Company (“Colgate”) and Klox Technologies Inc. (“KLOX”) have entered into agreements to globally commercialize and further develop KLOX’s human Oral Health technology platform. The agreements include a worldwide license to commercialize KLOX’s proprietary Biophotonic technology in the field of human Oral Health and an equity investment in KLOX by Colgate.
Dr. Lise Hébert, President and CEO of KLOX, stated: “We are extremely pleased to have Colgate-Palmolive, the leader in Oral Care, with activities in over 200 countries and territories be our global partner for our Oral Health platform. These agreements once again recognize the breadth of our technology platform. Furthermore, these agreements validate the value creation strategy we have adopted by partnering large potential indications with first in class partners, while building a specialized salesforce for products within Wound Care.”
Suzan Harrison, President of Global Oral Care of Colgate, stated: “We are very pleased to have KLOX as a partner in the development of this exciting and new technology platform for the benefit of Oral Health.”
About Colgate-Palmolive Company:
Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom’s of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet, Hill’s Prescription Diet and Hill’s Ideal Balance. For more information about Colgate’s global business, visit the Company’s web site at http://www.colgatepalmolive.com. To learn more about Colgate Bright Smiles, Bright Futures® oral health education program, please visit http://www.colgatebsbf.com.
About Klox Technologies Inc.:
KLOX is a specialty pharmaceutical company focused on developing and commercializing products based on its proprietary Biophotonic technology platform to address skin and soft tissue disorders. The company has a multi-franchise platform focusing on indications across Dermatology, Wound Care, and Oral Health.
To learn more about KLOX, please visit http://www.kloxtechnologies.com.
CONTACT: Colgate-Palmolive Company Media Contact: Mitali Chopra – mitali_chopra@colpal.com Klox Technologies Inc. Media Contact: Mr. Michael Rice – mrice@lifesciadvisors.com
